ARTICLE | Management Tracks
Semerjian to lead Geron
Plus: Stamoulis leaving as Incyte CFO, and updates from Acadia, T1D Fund, Certara, Om1
August 7, 2025 12:23 AM UTC
Geron Corp. (NASDAQ:GERN) named Harout Semerjian president, CEO and a director. Semerjian was CEO of Glycomimetics Inc. (NASDAQ:GLYC) and is a veteran of Novartis AG (SIX:NOVN; NYSE:NVS) and Ipsen Group (Euronext:IPN; Pink:IPSEY). Interim CEO Dawn Carter Bir will remain on the company’s board.
Christiana Stamoulis is stepping down as EVP and CFO of Incyte Corp. (NASDAQ:INCY) to pursue another opportunity, effective Sept. 16...